Enveric Biosciences(ENVB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ENVB Enveric Biosciences

六月节休市 06-18 16:00:00 EDT

1.28

-0.02

-1.54%

盘后1.33

+0.05+3.91%

19:59 EDT

最高1.33	最低1.26	成交量6.62万
今开1.31	昨收1.30	日振幅5.32%
总市值471.28万	流通市值378.13万	总股本368.19万
成交额8.54万	换手率2.24%	流通股本295.41万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ENVB","market":"US","secType":"STK","nameCN":"Enveric Biosciences","latestPrice":1.28,"timestamp":1781812800000,"preClose":1.3,"halted":0,"volume":66195,"hourTrading":{"tag":"盘后","latestPrice":1.33,"preClose":1.28,"latestTime":"19:59 EDT","volume":262,"amount":347.865,"timestamp":1781827163159,"change":0.05,"changeRate":0.039063,"amplitude":0.039063},"delay":0,"changeRate":-0.015384615384615398,"floatShares":2954143,"shares":3681900,"eps":-29.6654,"marketStatus":"六月节休市","change":-0.02,"latestTime":"06-18 16:00:00 EDT","open":1.31,"high":1.3292,"low":1.26,"amount":85372.87639050001,"amplitude":0.053231,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-29.6654,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1782115200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":1.3,"preHourTrading":{"tag":"盘前","latestPrice":1.31,"preClose":1.3,"latestTime":"09:29 EDT","volume":271,"amount":354.5900042,"timestamp":1781789340087,"change":0.01,"changeRate":0.007692,"amplitude":0.007692},"postHourTrading":{"tag":"盘后","latestPrice":1.33,"preClose":1.28,"latestTime":"19:59 EDT","volume":262,"amount":347.865,"timestamp":1781827163159,"change":0.05,"changeRate":0.039063,"amplitude":0.039063},"volumeRatio":0.130419,"impliedVol":6.7116,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/ENVB","defaultTab":"news","newsList":[{"id":"1132650418","title":"Enveric Biosciences启动先导神经塑形剂候选药物EB-003的研究性新药（IND）申报所需基因毒性研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1132650418","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132650418?lang=zh_cn&edition=full","pubTime":"2026-06-02 20:01","pubTimestamp":1780401688,"startTime":"0","endTime":"0","summary":"Enveric Biosciences已正式启动其先导神经塑形剂候选药物EB-003的研究性新药（IND）申报所需的关键基因毒性研究。这项进展标志着该候选药物在向临床开发阶段迈进的过程中，迈出了重要的监管准备步伐。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152538362","title":"Enveric Biosciences 公布其先导神经塑原候选药物 EB-003 光毒性分析取得积极临床前结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1152538362","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152538362?lang=zh_cn&edition=full","pubTime":"2026-05-19 20:01","pubTimestamp":1779192107,"startTime":"0","endTime":"0","summary":"Enveric Biosciences 近日宣布，其在研的先导神经塑原候选药物 EB-003 的光毒性分析取得了积极的临床前研究结果。该分析旨在评估药物在光照条件下对皮肤的潜在毒性影响，是药物开发中安全性评价的关键环节。初步数据显示，EB-003 在此项分析中表现出良好的安全性特征，未引发显著的光毒性反应。这一积极结果为该候选药物的后续临床开发路径提供了重要的支持数据，增强了其作为潜在治疗方案的可行性。公司表示，将继续推进 EB-003 的临床前研究，为未来进入临床试验阶段奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187912495","title":"Enveric Biosciences公司宣布其EB-003成为首个选择性靶向5-HT2A与5-HT1B受体的已知化合物","url":"https://stock-news.laohu8.com/highlight/detail?id=1187912495","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187912495?lang=zh_cn&edition=full","pubTime":"2026-05-19 20:01","pubTimestamp":1779192085,"startTime":"0","endTime":"0","summary":"Enveric Biosciences公司披露，其候选药物EB-003已成为首个已知能选择性同时作用于5-HT2A和5-HT1B受体的化合物。这一发现标志着该公司在神经精神疾病治疗领域的研发取得了重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ENVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127317375","title":"Enveric Biosciences宣布以纳斯达克规则下市价定价，进行最高1390万美元的私募配售","url":"https://stock-news.laohu8.com/highlight/detail?id=1127317375","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127317375?lang=zh_cn&edition=full","pubTime":"2026-04-17 08:02","pubTimestamp":1776384166,"startTime":"0","endTime":"0","summary":"生物科技公司Enveric Biosciences披露了一项融资计划，拟通过私募配售筹集最高达1390万美元的资金。此次发行将依据纳斯达克市场的相关规则，采用市价定价机制进行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162624367","title":"Enveric Biosciences公布2025财年第四季度及全年财务业绩并更新公司进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1162624367","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162624367?lang=zh_cn&edition=full","pubTime":"2026-03-28 05:40","pubTimestamp":1774647612,"startTime":"0","endTime":"0","summary":"Enveric Biosciences近日公布了截至2025财年第四季度及全年的财务业绩报告，同时向市场更新了公司的最新运营动态。此次披露涵盖了公司在指定会计期间内的关键财务数据与业务发展重要节点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ENVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180744155","title":"Enveric Biosciences宣布吉尔伽美什制药公司撤回对其专利的授权后复审请求","url":"https://stock-news.laohu8.com/highlight/detail?id=1180744155","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180744155?lang=zh_cn&edition=full","pubTime":"2026-02-25 21:09","pubTimestamp":1772024954,"startTime":"0","endTime":"0","summary":"生物制药公司Enveric Biosciences今日发布公告，宣布吉尔伽美什制药公司已正式撤回此前针对Enveric Biosciences一项专利所提出的授权后复审请求。\n这一进展标志着Enveric Biosciences在维护其知识产权方面取得了重要成果。专利是生物技术公司的核心资产，成功捍卫专利有助于保障公司的研发投入价值和未来市场潜力。\n随着挑战的撤消，Enveric Biosciences可以更专注于推进其神经精神疾病治疗药物的研发管线。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614848707","title":"Enveric Biosciences, Inc.盘中异动 大幅拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614848707","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614848707?lang=zh_cn&edition=full","pubTime":"2026-02-24 23:16","pubTimestamp":1771946212,"startTime":"0","endTime":"0","summary":"北京时间2026年02月24日23时16分，Enveric Biosciences, Inc.股票出现波动，股价快速上涨5.04%。Enveric Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Enveric Biosciences, Inc.公司简介：Enveric Biosciences Inc是一家生物技术公司，致力于开发新型神经质体小分子疗法，用于治疗抑郁症、焦虑症和成瘾性疾病和其他精神疾病的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224231652a4c389dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224231652a4c389dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ENVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611908242","title":"Enveric Biosciences, Inc.盘中异动 临近午盘快速下挫5.21%报2.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611908242","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611908242?lang=zh_cn&edition=full","pubTime":"2026-02-13 00:55","pubTimestamp":1770915332,"startTime":"0","endTime":"0","summary":"北京时间2026年02月13日00时55分，Enveric Biosciences, Inc.股票出现异动，股价急速下跌5.21%。Enveric Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.22%。Enveric Biosciences, Inc.公司简介：Enveric Biosciences Inc是一家生物技术公司，致力于开发新型神经质体小分子疗法，用于治疗抑郁症、焦虑症和成瘾性疾病和其他精神疾病的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213005532a49d413c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213005532a49d413c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610939021","title":"Enveric Biosciences, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610939021","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610939021?lang=zh_cn&edition=full","pubTime":"2026-02-11 02:14","pubTimestamp":1770747251,"startTime":"0","endTime":"0","summary":"北京时间2026年02月11日02时14分，Enveric Biosciences, Inc.股票出现异动，股价快速拉升5.00%。Enveric Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Enveric Biosciences, Inc.公司简介：Enveric Biosciences Inc是一家生物技术公司，致力于开发新型神经质体小分子疗法，用于治疗抑郁症、焦虑症和成瘾性疾病和其他精神疾病的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021102141197a5aec1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021102141197a5aec1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ENVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157934281","title":"Enveric Biosciences拟通过Wainwright不定期发售总价高达130万美元普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1157934281","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157934281?lang=zh_cn&edition=full","pubTime":"2026-02-07 05:34","pubTimestamp":1770413688,"startTime":"0","endTime":"0","summary":"生物制药公司Enveric Biosciences宣布，其可能通过承销商Wainwright不定期发售公司普通股，本次发行的股票总价值最高可达130万美元。该融资安排将为公司提供灵活的资金募集渠道。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ENVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150232488","title":"Enveric Biosciences宣布以纳斯达克规则下市价定价的150万美元注册直接发行","url":"https://stock-news.laohu8.com/highlight/detail?id=1150232488","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150232488?lang=zh_cn&edition=full","pubTime":"2026-01-28 21:07","pubTimestamp":1769605653,"startTime":"0","endTime":"0","summary":"Enveric Biosciences今日披露，其已正式启动一项注册直接发行计划，拟融资总额达150万美元。该发行严格遵循纳斯达克资本市场的相关规则，发行价格将按“市价定价”机制确定，旨在高效对接当前市场环境与投资者需求。公司表示，本次发行所得款项将主要用于推进其在神经科学领域的创新疗法研究，并补充营运资金。此举有望进一步巩固Enveric Biosciences在精神健康治疗领域的探索优势，为长期价值释放奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ENVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518046279","title":"Enveric Biosciences, Inc.盘中异动 股价大跌6.04%报1.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518046279","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518046279?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:50","pubTimestamp":1741614649,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时50分，Enveric Biosciences, Inc.股票出现波动，股价快速下挫6.04%。Enveric Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2772.41%、624.18%、107.11%，振幅较大的相关个股有Scisparc Ltd.、Impact Biomedical, Inc.、Trevi Therapeutics, Inc.，振幅分别为40.24%、28.59%、25.35%。Enveric Biosciences, Inc.公司简介：Enveric Biosciences Inc是一家生物技术公司，致力于开发新型神经质体小分子疗法，用于治疗抑郁症、焦虑症和成瘾性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310215049abf303b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310215049abf303b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517161389","title":"Enveric Biosciences, Inc.盘中异动 早盘股价大跌7.14%报1.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517161389","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517161389?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:59","pubTimestamp":1741273153,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时59分，Enveric Biosciences, Inc.股票出现波动，股价快速下跌7.14%。Enveric Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.63%。其相关个股中，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Alx Oncology Holdings Inc.涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Aditxt, Inc.较为活跃，换手率分别为1403.46%、570.37%、68.21%，振幅较大的相关个股有Moolec Science Sa C/Wts 、Aeon Biopharma, Inc.、Plus Therapeutics, Inc.，振幅分别为100.00%、41.05%、33.60%。Enveric Biosciences, Inc.公司简介：Enveric Biosciences Inc是一家生物技术公司，致力于开发新型神经质体小分子疗法，用于治疗抑郁症、焦虑症和成瘾性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306225913a26297a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306225913a26297a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516267784","title":"Enveric Biosciences, Inc.盘中异动 急速跳水5.77%报2.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516267784","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516267784?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:38","pubTimestamp":1741099138,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时38分，Enveric Biosciences, Inc.股票出现波动，股价快速下挫5.77%。Enveric Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Exicure, Inc.涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1101.58%、1094.29%、429.22%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Hepion Pharmaceuticals, Inc.、Windtree Therapeutics, Inc.，振幅分别为37.67%、22.25%、19.21%。Enveric Biosciences, Inc.公司简介：Enveric Biosciences Inc是一家生物技术公司，致力于开发新型神经质体小分子疗法，用于治疗抑郁症、焦虑症和成瘾性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223859a25f0704&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223859a25f0704&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ENVB"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2516663443","title":"Enveric Biosciences, Inc.股价重挫10.00% 市值跌48.43万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516663443","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516663443?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:35","pubTimestamp":1741012501,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时35分，Enveric Biosciences, Inc.股票出现异动，股价快速下跌10.00%。Enveric Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Geovax Labs, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为48.16%、30.52%、29.09%，振幅较大的相关个股有Entero Therapeutics Inc.、Spruce Biosciences, Inc.、Pliant Therapeutics, Inc.，振幅分别为21.22%、19.25%、15.49%。Enveric Biosciences, Inc.公司简介：Enveric Biosciences Inc是一家生物技术公司，致力于开发新型神经质体小分子疗法，用于治疗抑郁症、焦虑症和成瘾性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223501a25d40ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223501a25d40ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2514532024","title":"Enveric Biosciences, Inc.盘中异动 早盘股价大涨25.47%报2.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514532024","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514532024?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:32","pubTimestamp":1740753163,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时32分，Enveric Biosciences, Inc.股票出现异动，股价大幅拉升25.47%。Enveric Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Enveric Biosciences, Inc.公司简介：Enveric Biosciences Inc是一家生物技术公司，致力于开发新型神经质体小分子疗法，用于治疗抑郁症、焦虑症和成瘾性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223243a2580191&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223243a2580191&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ENVB"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2514856610","title":"Enveric Biosciences, Inc.盘中异动 早盘快速上涨187.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856610","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514856610?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:32","pubTimestamp":1740580347,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时32分，Enveric Biosciences, Inc.股票出现异动，股价急速拉升187.29%。Enveric Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Enveric Biosciences, Inc.、Nutriband Inc C/Wts 、Channel Therapeutics Corporation涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为2837.58%、119.45%、90.45%，振幅较大的相关个股有Enveric Biosciences, Inc.、Channel Therapeutics Corporation、Cns Pharmaceuticals, Inc.，振幅分别为35.59%、16.86%、14.35%。Enveric Biosciences, Inc.公司简介：Enveric Biosciences Inc是一家生物技术公司，致力于开发新型神经质体小分子疗法，用于治疗抑郁症、焦虑症和成瘾性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223227a254f6ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223227a254f6ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ENVB"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2514013027","title":"Enveric Biosciences, Inc.盘中异动 股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514013027","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514013027?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:06","pubTimestamp":1740496000,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时06分，Enveric Biosciences, Inc.股票出现异动，股价急速跳水5.11%。Enveric Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.94%。Enveric Biosciences, Inc.公司简介：Enveric Biosciences Inc是一家生物技术公司，致力于开发新型神经质体小分子疗法，用于治疗抑郁症、焦虑症和成瘾性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225230640989254bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225230640989254bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513372038","title":"Enveric Biosciences, Inc.盘中异动 快速上涨5.88%报1.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513372038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513372038?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:32","pubTimestamp":1740407531,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时32分，Enveric Biosciences, Inc.股票出现波动，股价快速上涨5.88%。Enveric Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Psyence Biomedical Ltd C/Wts 25/01/2029、Nutriband Inc C/Wts 涨幅较大，Aditxt, Inc.、Biodexa Pharmaceuticals Plc、Acurx Pharmaceuticals, Inc.较为活跃，换手率分别为40.26%、24.06%、17.71%，振幅较大的相关个股有Gossamer Bio, Inc.、Summit Therapeutics Inc.、Estrella Immunopharma, Inc.，振幅分别为14.69%、12.61%、12.38%。Enveric Biosciences, Inc.公司简介：Enveric Biosciences Inc是一家生物技术公司，致力于开发新型神经质体小分子疗法，用于治疗抑郁症、焦虑症和成瘾性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223211a2521474&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223211a2521474&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ENVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512431096","title":"Enveric Biosciences, Inc.盘中异动 快速下挫5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512431096","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512431096?lang=zh_cn&edition=full","pubTime":"2025-02-20 04:59","pubTimestamp":1739998793,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日04时59分，Enveric Biosciences, Inc.股票出现异动，股价快速下跌5.06%。Enveric Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.90%。其相关个股中，Editas Medicine, Inc.、Osr Holdings, Inc.、Osr Holdings Inc C/Wts 02/09/2028 涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为720.59%、261.85%、236.83%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Surrozen Inc C/Wts 01/08/2031 、Osr Holdings, Inc.，振幅分别为288.38%、280.70%、160.77%。Enveric Biosciences, Inc.公司简介：Enveric Biosciences Inc是一家生物技术公司，致力于开发新型神经质体小分子疗法，用于治疗抑郁症、焦虑症和成瘾性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022004595496290a9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022004595496290a9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.enveric.com","stockEarnings":[{"period":"1week","weight":-0.2289},{"period":"1month","weight":-0.3934},{"period":"3month","weight":-0.3725},{"period":"6month","weight":-0.748},{"period":"1year","weight":-0.9153},{"period":"ytd","weight":-0.6474}],"compareEarnings":[{"period":"1week","weight":0.0122},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.1514},{"period":"6month","weight":0.0972},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.0951}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Enveric Biosciences, Inc.于1994年2月根据特拉华州法律成立。Enveric Biosciences是一家生物技术公司，致力于开发新一代小分子神经可塑性疗法，以满足精神和神经系统疾病领域尚未满足的医疗需求。该公司利用其独特的药物发现平台和不断增长的专利保护化学结构库，推进一系列旨在促进神经可塑性且不产生致幻作用的新型化合物的研发。其主要候选药物EB-003是一种旨在选择性地与5-HT2A和5-HT1B受体结合的化合物，有望提供快速起效、持久的抗抑郁和抗焦虑作用，适用于门诊治疗。","yearOnYearQuotes":[{"month":1,"riseRate":0.222222,"avgChangeRate":-0.176137},{"month":2,"riseRate":0.333333,"avgChangeRate":0.037546},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.164315},{"month":4,"riseRate":0.333333,"avgChangeRate":0.030879},{"month":5,"riseRate":0.222222,"avgChangeRate":0.034325},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.003955},{"month":7,"riseRate":0.375,"avgChangeRate":-0.077722},{"month":8,"riseRate":0.375,"avgChangeRate":-0.104625},{"month":9,"riseRate":0.375,"avgChangeRate":-0.104281},{"month":10,"riseRate":0.125,"avgChangeRate":-0.243904},{"month":11,"riseRate":0.375,"avgChangeRate":1.818773},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.152619}],"exchange":"NASDAQ","name":"Enveric Biosciences","nameEN":"Enveric Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Enveric Biosciences(ENVB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Enveric Biosciences(ENVB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Enveric Biosciences,ENVB,Enveric Biosciences股票,Enveric Biosciences股票老虎,Enveric Biosciences股票老虎国际,Enveric Biosciences行情,Enveric Biosciences股票行情,Enveric Biosciences股价,Enveric Biosciences股市,Enveric Biosciences股票价格,Enveric Biosciences股票交易,Enveric Biosciences股票购买,Enveric Biosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Enveric Biosciences(ENVB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Enveric Biosciences(ENVB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}